Uterine carcinosarcoma

Immunohistochemical analysis of the epithelial to mesenchymal transition in uterine carcinosarcoma
Mitsumasa Osakabe, Daisuke Fukagawa, Chie Sato, Ryo Sugimoto, Noriyuki Uesugi, Kazuyuki Ishida, Hiroaki Itamochi, Toru Sugiyama, Tamotsu Sugai

International Journal of Gynecologic Cancer Feb 2019, 29 (2) 277-281; DOI: 10.1136/ijgc-2018-000038
Role of Radiation Therapy in the Multidisciplinary Management of Uterine Carcinosarcoma
Jillian R. Gunther, Eva N. Christensen, Pamela K. Allen, Lois M. Ramondetta, Anuja Jhingran, Nicole D. Fleming, Elizabeth D. Euscher, Karen H. Lu, Patricia J. Eifel, Ann H. Klopp

International Journal of Gynecologic Cancer Jan 2018, 28 (1) 114-121; DOI: 10.1097/IGC.0000000000001135
Fascin Is Associated With Aggressive Behavior and Poor Outcome in Uterine Carcinosarcoma
Abby M. Richmond, Erin A. Blake, Kathleen Torkko, Elizabeth E. Smith, Monique A. Spillman, Miriam D. Post

International Journal of Gynecologic Cancer Nov 2017, 27 (9) 1895-1903; DOI: 10.1097/IGC.0000000000001077
Paclitaxel and Carboplatin in Patients With Completely or Optimally Resected Carcinosarcoma of the Uterus: A Phase II Trial by the Japanese Uterine Sarcoma Group and the Tohoku Gynecologic Cancer Unit
Ai Otsuki, Yoh Watanabe, Hiroyuki Nomura, Masayuki Futagami, Yoshihito Yokoyama, Kiyosumi Shibata, Seiryu Kamoi, Atsushi Arakawa, Hiroshi Nishiyama, Takahiro Katsuta, Wataru Kudaka, Muneaki Shimada, Naoki Sato, Kouhei Kotera, Hidetaka Katabuchi, Nobuo Yaegashi

International Journal of Gynecologic Cancer Jan 2015, 25 (1) 92-97; DOI: 10.1097/IGC.0000000000000302
Treatment Outcomes in Completely Resected Stage I to Stage IV Uterine Carcinosarcoma With Rhabdomyosarcoma Differentiation
Vicky Makker, Sara J. Kravetz, Jacqueline Gallagher, Oana-Paula Orodel, Qin Zhou, Alexia Iasonos, Deborah DeLair, Carol Aghajanian, Martee L. Hensley

International Journal of Gynecologic Cancer Nov 2013, 23 (9) 1635-1641; DOI: 10.1097/IGC.0000000000000001
Prognostic Value of Alternative Lengthening of Telomeres–Associated Biomarkers in Uterine Sarcoma and Uterine Carcinosarcoma
Yoo-Kyung Lee, Noh-Hyun Park, Hyunsook Lee

International Journal of Gynecologic Cancer Mar 2012, 22 (3) 434-441; DOI: 10.1097/IGC.0b013e31823ca017
Ovarian and Uterine Carcinosarcomas: A Comparative Analysis of Prognostic Variables and Survival Outcomes
Gunjal Garg, Jay P. Shah, Sanjeev Kumar, Christopher S. Bryant, Adnan Munkarah, Robert T. Morris

International Journal of Gynecologic Cancer Jun 2010, 20 (5) 888-894; DOI: 10.1111/IGC.0b013e3181dc8292
Phase II Study Evaluating PegLiposomal Doxorubicin and Carboplatin Combination Chemotherapy in Gynecologic Sarcomas and Mixed Epithelial-Mesenchymal Tumors A Phase II Protocol of the Arbeitsgemeinschaft Gynaekologische Onkologie Study Group (AGO-GYN 7)
Philipp Harter, Jalid Sehouli, Alexander Reuss, Klaus Baumann, Lars Hanker, Rainer Kimmig, Willibald Schröder, Alexander Burges, Martina Gropp-Meier, Christian Kurzeder, Sven Mahner, Ulrich Canzler, Hans-Joachim Lück, Werner Meier, Tanja Fehm, Andreas du Bois

International Journal of Gynecologic Cancer Nov 2016, 26 (9) 1636-1641; DOI: 10.1097/IGC.0000000000000831
Uterine Carcinosarcoma and High-Risk Endometrial Carcinomas: A Clinicopathological Comparison
Chuyao Zhang, Weiguo Hu, Nan Jia, Qing Li, Keqin Hua, Xiang Tao, Li Wang, Weiwei Feng

International Journal of Gynecologic Cancer May 2015, 25 (4) 629-636; DOI: 10.1097/IGC.0000000000000350
Prognostic Significance of omental Disease and the Role of Omental Sampling in Patients With Uterine Carcinosarcoma
Malcolm Strachan Ross, Esther Elishaev, Jessica Layne Berger, Joseph Leo Kelley, Sarah Elizabeth Taylor

International Journal of Gynecologic Cancer Feb 2018, 28 (2) 254-259; DOI: 10.1097/IGC.0000000000001176

Main menu

Uterine carcinosarcoma

Pages

Log in using your username and password

Main menu

Log in using your username and password

You are here

Uterine carcinosarcoma

Pages